UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Raised by Investors Asset Management of Georgia Inc. GA ADV

Investors Asset Management of Georgia Inc. GA ADV lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,415 shares of the healthcare conglomerate’s stock after buying an additional 29 shares during the period. Investors Asset Management of Georgia Inc. GA ADV’s holdings in UnitedHealth Group were worth $553,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in UNH. Amundi bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at about $680,292,000. Jennison Associates LLC boosted its stake in UnitedHealth Group by 205.8% during the 2nd quarter. Jennison Associates LLC now owns 1,947,717 shares of the healthcare conglomerate’s stock valued at $779,944,000 after purchasing an additional 1,310,783 shares during the period. Macquarie Group Ltd. boosted its stake in UnitedHealth Group by 311.9% during the 2nd quarter. Macquarie Group Ltd. now owns 1,622,199 shares of the healthcare conglomerate’s stock valued at $649,595,000 after purchasing an additional 1,228,389 shares during the period. State Street Corp boosted its stake in UnitedHealth Group by 1.9% during the 2nd quarter. State Street Corp now owns 44,530,535 shares of the healthcare conglomerate’s stock valued at $17,831,807,000 after purchasing an additional 838,941 shares during the period. Finally, Morgan Stanley boosted its stake in UnitedHealth Group by 9.7% during the 2nd quarter. Morgan Stanley now owns 8,693,237 shares of the healthcare conglomerate’s stock valued at $3,481,120,000 after purchasing an additional 768,188 shares during the period. 86.20% of the stock is owned by institutional investors and hedge funds.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of UnitedHealth Group stock in a transaction dated Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction that occurred on Friday, September 17th. The shares were sold at an average price of $419.00, for a total value of $1,047,500.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 82,500 shares of company stock worth $36,855,125. Company insiders own 0.55% of the company’s stock.

NYSE UNH opened at $450.16 on Thursday. The firm’s 50 day moving average price is $430.47 and its two-hundred day moving average price is $418.01. The stock has a market cap of $423.98 billion, a price-to-earnings ratio of 27.93, a PEG ratio of 1.75 and a beta of 0.85. UnitedHealth Group Incorporated has a twelve month low of $320.35 and a twelve month high of $466.00. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.77 and a current ratio of 0.77.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, beating analysts’ consensus estimates of $4.41 by $0.11. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The business had revenue of $72.34 billion for the quarter, compared to the consensus estimate of $71.24 billion. During the same quarter in the previous year, the company posted $3.51 earnings per share. UnitedHealth Group’s revenue for the quarter was up 11.1% compared to the same quarter last year. On average, research analysts forecast that UnitedHealth Group Incorporated will post 18.84 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th will be paid a dividend of $1.45 per share. The ex-dividend date is Friday, December 3rd. This represents a $5.80 annualized dividend and a yield of 1.29%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.98%.

A number of research analysts have issued reports on the stock. SVB Leerink assumed coverage on shares of UnitedHealth Group in a research note on Monday, September 27th. They set an “outperform” rating and a $480.00 target price for the company. Credit Suisse Group boosted their target price on shares of UnitedHealth Group from $462.00 to $495.00 and gave the company an “outperform” rating in a research note on Friday, October 15th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 price objective on the stock in a research note on Wednesday, October 27th. Evercore ISI upped their target price on UnitedHealth Group from $360.00 to $480.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. Finally, Wells Fargo & Company lifted their price target on UnitedHealth Group from $478.00 to $520.00 and gave the company an “overweight” rating in a research report on Monday, October 25th. One research analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $477.35.

About UnitedHealth Group

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Recommended Story: How a Strangle Strategy is different from a Straddle Strategy

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.